These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2648967)

  • 61. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.
    Liu AY; Charron J; Fugaro D; Spoolstra S; Kaplan R; Lohrmann G; Gao X; Gay H; Passman R; Kim S; Lin AC; Chicos A; Arora R; Patil K; Pfenniger A; Knight BP; Verma N
    J Cardiovasc Electrophysiol; 2023 Mar; 34(3):502-506. PubMed ID: 36640424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term experience with sotalol in the treatment of complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Askins JC; Gilbert EM; Nanas JN; Menlove RL
    Am Heart J; 1987 Aug; 114(2):288-96. PubMed ID: 3604885
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias.
    Hohnloser SH; Klingenheben T; Zabel M; Just H
    Am J Cardiol; 1993 Aug; 72(4):67A-71A. PubMed ID: 8346729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Data from systematic electrocardiographic study during exercise in hypertensive patients. Apropos of 307 cases].
    Mallion JM; Debru JL; Mikler F; Grubier M; Laulhere L; Muller JM; Cau G
    Arch Mal Coeur Vaiss; 1976 Dec; 69(12):1297-1304. PubMed ID: 827267
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study.
    Lidell C; Rehnqvist N; Sjögren A; Yli-Uotila RJ; Rønnevik PK
    Am Heart J; 1985 May; 109(5 Pt 1):970-5. PubMed ID: 3887877
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Special symposium: Improvement of Therapy of Cardiac Arrhythmias. Class III Antiarrhythmic Drugs Focussing on Sotalol and D-Sotalol. Nizza, 17-20 June 1992].
    Fortschr Med Suppl; 1992; 135():1-18. PubMed ID: 1358774
    [No Abstract]   [Full Text] [Related]  

  • 67. Sotalol: a new agent for the treatment of ventricular arrhythmias.
    Samoil D; Grubb BP; Temesy-Armos PN
    Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relation between ventricular function and antiarrhythmic responses to sotalol.
    Singh SN; Chen YW; Cohen A; Obeid M; Tracy C; Woosley RL; Fletcher RD
    Am J Cardiol; 1989 Oct; 64(14):943-5. PubMed ID: 2801566
    [No Abstract]   [Full Text] [Related]  

  • 69. Concentration-dependent pharmacologic properties of sotalol.
    Wang T; Bergstrand RH; Thompson KA; Siddoway LA; Duff HJ; Woosley RL; Roden DM
    Am J Cardiol; 1986 May; 57(13):1160-5. PubMed ID: 3706170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study.
    Burckhardt D; Pfisterer M; Hoffmann A; Burkart F; Emmenegger H; Jost M; Bolli P; Buehler FR
    Cardiology; 1983; 70 Suppl 1():114-21. PubMed ID: 6342778
    [No Abstract]   [Full Text] [Related]  

  • 71. Sleep and night-type arrhythmias.
    Otsuka K; Yanaga T; Ichimaru Y; Seto K
    Jpn Heart J; 1982 Jul; 23(4):479-86. PubMed ID: 6182313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sotalol prolongation of the QTc interval in hypertensive patients.
    Neuvonen PJ; Elonen E; Tanskanen A; Tuomilehto J
    Clin Pharmacol Ther; 1982 Jul; 32(1):25-32. PubMed ID: 7083728
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypertension and cardiac arrhythmias.
    Aidietis A; Laucevicius A; Marinskis G
    Curr Pharm Des; 2007; 13(25):2545-55. PubMed ID: 17896999
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical analysis of cardiac arrhythmias in patients with chronic renal failure treated conservatively. I. Evaluation of cardiac arrhythmias].
    Mamczur D; Kidawa Z
    Pol Arch Med Wewn; 1993 Dec; 90(6):438-44. PubMed ID: 8146048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sotalol: a beta blocker with unique antiarrhythmic properties.
    Singh BN; Nademanee K
    Am Heart J; 1987 Jul; 114(1 Pt 1):121-39. PubMed ID: 3300230
    [No Abstract]   [Full Text] [Related]  

  • 76. Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication.
    Neuvonen PJ; Elonen E; Vuorenmaa T; Laakso M
    Eur J Clin Pharmacol; 1981; 20(2):85-9. PubMed ID: 7262178
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IV Sotalol Use in Pediatric and Congenital Heart Patients: A Multicenter Registry Study.
    Malloy-Walton LE; Von Bergen NH; Balaji S; Fischbach PS; Garnreiter JM; Asaki SY; Moak JP; Ochoa LA; Chang PM; Nguyen HH; Patel AR; Kirk C; Sherman AK; Avari Silva JN; Saul JP
    J Am Heart Assoc; 2022 May; 11(9):e024375. PubMed ID: 35491986
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exercise-induced arrhythmias in diuretic-treated patients with uncomplicated systemic hypertension.
    Bause GS; Fleg JL; Lakatta EG
    Am J Cardiol; 1987 Apr; 59(8):874-7. PubMed ID: 3825952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sotalol: a unique class III antiarrhythmic agent.
    Barlow JB; Obel IW; Pocock WA; McKibbin JK
    Am J Cardiol; 1994 May; 73(12):932-3. PubMed ID: 8018196
    [No Abstract]   [Full Text] [Related]  

  • 80. [Current application of sotalol in treatment of pediatric cardiac arrhythmia].
    Wu L; He L
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):41-3. PubMed ID: 19573381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.